Clinical Trials on Visual Correction in New Zealand
Total 2619 results
-
Johnson & Johnson Vision Care, Inc.CompletedVision CorrectionUnited States, Canada
-
TKL Research, Inc.Nordson MicromedicsUnknownCorrection of Nasolabial FoldsUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Merz North America, Inc.CompletedCorrection of Volume Loss in the Infraorbital Hollow AreaUnited States
-
Smith & Nephew, Inc.RecruitingAvascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other TechniquesNew Zealand, Australia, Hong Kong
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Gilead SciencesCompleted
-
Alios Biopharma Inc.Completed
-
University of Auckland, New ZealandCompletedVaccinationNew Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Novartis PharmaceuticalsTerminated
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Gilead SciencesCompleted
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arrowhead PharmaceuticalsTerminated
-
Assembly BiosciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand